Alberta Investment Management Corp (AIMCo)’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-3,800
Closed -$1.26M – 1378
2022
Q1
$1.26M Hold
3,800
– – 0.01% 903
2021
Q4
$1.36M Hold
3,800
– – 0.01% 678
2021
Q3
$1.24M Hold
3,800
– – 0.01% 738
2021
Q2
$1.19M Buy
+3,800
New +$1.17M 0.01% 751
2021
Q1
– Sell
-44,367
Closed -$14.4M – 948
2020
Q4
$14.4M Sell
44,367
-6,513
-13% -$1.8M 0.13% 183
2020
Q3
$14.1M Hold
50,880
– – 0.15% 159
2020
Q2
$12.3M Buy
50,880
+8,217
+19% +$1.65M 0.15% 167
2020
Q1
$6.19M Buy
42,663
+7,856
+23% +$1.3M 0.11% 224
2019
Q4
$5.94M Buy
34,807
+10,007
+40% +$1.86M 0.05% 315
2019
Q3
$4.41M Hold
24,800
– – 0.04% 364
2019
Q2
$6.46M Buy
24,800
+11,500
+86% +$3.05M 0.06% 291
2019
Q1
$3.8M Buy
13,300
+2,300
+21% +$764K 0.04% 379
2018
Q4
$3.58M Sell
11,000
-1,200
-10% -$417K 0.04% 335
2018
Q3
$5.49M Buy
+12,200
New +$4.81M 0.05% 327

Other funds holding ABMD

Alberta Investment Management Corp (AIMCo)'s ABMD Position: Q2 2022 in Review

Alberta Investment Management Corp (AIMCo) sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 3,800 shares — an estimated $1.26M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ABMD in Q3 2018 and held it in 14 quarters. The position peaked at $14.4M in Q4 2020. 495 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 3,800 Abiomed Inc shares in Q2 2022, an estimated $1.26M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Abiomed Inc in Q3 2018 and held it in 14 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Abiomed Inc position peaked at $14.4M in Q4 2020.
  • 495 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2022, filed 15 Aug 2022.